{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:25:51Z","timestamp":1790630751408,"version":"4.1.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,15]]},"DOI":"10.1093\/cid\/civ491","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T00:33:10Z","timestamp":1447115590000},"page":"S428-S433","source":"Crossref","is-referenced-by-count":11,"title":["Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries"],"prefix":"10.1093","volume":"61","author":[{"given":"Nora","family":"Dellepiane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartholomew Dicky","family":"Akanmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Gairola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh S.","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"key\n\t\t\t\t20171013225050_CIV491C1","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/j.vaccine.2011.03.008","article-title":"Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries","volume":"29","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171013225050_CIV491C2","first-page":"1536","article-title":"Regulation and testing of vaccines","volume-title":"Vaccines","year":"2004","edition":"5th ed"},{"key":"key\n\t\t\t\t20171013225050_CIV491C3","article-title":"Procedure for assessing the acceptability, in principle, of vaccines for purchase by United Nations agencies"},{"key":"key\n\t\t\t\t20171013225050_CIV491C4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vaccine.2013.11.066","article-title":"Twenty-five years of WHO vaccines prequalification programme (1987\u20132012). Lessons learned and future perspectives","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171013225050_CIV491C5","article-title":"GPV policy statement. Statement on vaccine quality","author":"World Health Organization","year":"1996"},{"key":"key\n\t\t\t\t20171013225050_CIV491C6","first-page":"121","article-title":"Assuring vaccine quality by strengthening regulatory agencies: the work of the World Health Organization","volume-title":"New generation of vaccines","year":"2010","edition":"4th ed"},{"key":"key\n\t\t\t\t20171013225050_CIV491C7","first-page":"1454","article-title":"Regulation of vaccines in developing countries","volume-title":"Vaccines","year":"2013","edition":"6th ed"},{"key":"key\n\t\t\t\t20171013225050_CIV491C8","article-title":"Procedure for expedited review of imported prequalified vaccines for use in national immunization programmes"},{"key":"key\n\t\t\t\t20171013225050_CIV491C9","article-title":"Requirements and guidelines for the permission to import and\/or manufacture of new drugs for sale or to undertake clinical trials, part (iv) (b) Schedule Y of drugs and cosmetic rules"},{"key":"key\n\t\t\t\t20171013225050_CIV491C10","article-title":"Collaborative procedure between the World Health Organization prequalification of Medicines Programme (WHO\/PQP) and national medicines regulatory authorities (NMRAs) in the assessment and accelerate national registration of WHO-prequalified pharmaceutical products and vaccines"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/61\/suppl_5\/S428\/20913937\/civ491.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T02:50:57Z","timestamp":1507949457000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/61\/suppl_5\/S428\/417512\/Regulatory-Pathways-That-Facilitated-Timely"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":10,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2015,11,9]]},"published-print":{"date-parts":[[2015,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ491","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,11,15]]},"published":{"date-parts":[[2015,11,9]]}}}